Secondary |
Drug Use For Unknown Indication |
17.1% |
Psoriasis |
17.1% |
Suicide Attempt |
11.4% |
Arthralgia |
8.6% |
Foetal Exposure During Pregnancy |
5.7% |
Memory Impairment |
5.7% |
Pyrexia |
5.7% |
Rash |
5.7% |
Autoimmune Hepatitis |
2.9% |
Depression |
2.9% |
Hypertension |
2.9% |
Irritable Bowel Syndrome |
2.9% |
Macular Degeneration |
2.9% |
Parkinson's Disease |
2.9% |
Seizure |
2.9% |
Weight Control |
2.9% |
|
Retinoic Acid Syndrome |
10.0% |
Toxic Epidermal Necrolysis |
10.0% |
Abdominal Pain Upper |
5.0% |
Diarrhoea |
5.0% |
Ear Infection |
5.0% |
Memory Impairment |
5.0% |
Muscle Spasms |
5.0% |
Nausea |
5.0% |
On And Off Phenomenon |
5.0% |
Oropharyngeal Pain |
5.0% |
Respiratory Disorder Neonatal |
5.0% |
Salt Craving |
5.0% |
Stevens-johnson Syndrome |
5.0% |
Tachycardia |
5.0% |
Therapeutic Response Unexpected |
5.0% |
Urine Odour Abnormal |
5.0% |
Weight Increased |
5.0% |
Wrong Drug Administered |
5.0% |
|
Concomitant |
Drug Use For Unknown Indication |
21.7% |
Product Used For Unknown Indication |
14.0% |
Hypertension |
7.7% |
Crohn's Disease |
5.6% |
Rheumatoid Arthritis |
5.2% |
Pain |
4.6% |
Vitamin Supplementation |
4.3% |
Chronic Obstructive Pulmonary Disease |
3.9% |
Depression |
3.7% |
Blood Cholesterol Increased |
3.2% |
Medical Diet |
3.2% |
Gastrooesophageal Reflux Disease |
3.1% |
Hepatitis C |
2.9% |
Prophylaxis |
2.9% |
Asthma |
2.7% |
Anxiety |
2.6% |
Atrial Fibrillation |
2.5% |
Routine Health Maintenance |
2.4% |
Diabetes Mellitus |
2.0% |
Supplementation Therapy |
1.9% |
|
Vomiting |
9.1% |
Weight Increased |
9.1% |
Weight Decreased |
6.6% |
Vision Blurred |
6.3% |
Rash |
5.4% |
Pain In Extremity |
5.1% |
Drug Ineffective |
4.8% |
Nausea |
4.8% |
Pain |
4.8% |
Product Quality Issue |
4.8% |
Wrong Technique In Drug Usage Process |
4.8% |
Pneumonia |
4.5% |
Dyspnoea |
4.2% |
Pruritus |
4.2% |
Oedema Peripheral |
3.9% |
Somnolence |
3.9% |
Fatigue |
3.6% |
Myocardial Infarction |
3.6% |
Headache |
3.0% |
Urinary Tract Infection |
3.0% |
|
Interacting |
Product Used For Unknown Indication |
77.8% |
Contraception |
11.1% |
Pharyngitis |
11.1% |
|
Maternal Exposure During Pregnancy |
100.0% |
|